Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Nektar Therapeutics”

423 pharma patents match "Nektar Therapeutics" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 423
Index total 30,257
Page 15 / 18

Quick answer

This filtered view shows 423 pharmaceutical patents matching "Nektar Therapeutics" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

423 results for “Nektar Therapeutics” · 30,257 patents in full index Clear search

  1. US 7723432

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted May 25, 2010 · Expires May 20, 2030

    granted
  2. US 7714088

    Poly(ethylene glycol) derivatives with proximal reactive groups

    Nektar Therapeutics · Granted May 11, 2010 · Expires May 6, 2030

    granted
  3. US 7714114

    Conjugates of an EPO moiety and a polymer

    Nektar Therapeutics · Granted May 11, 2010 · Expires May 6, 2030

    granted
  4. US 7674879

    Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

    Nektar Therapeutics · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  5. US 7662365

    Polymer conjugates of opioid antagonists

    Nektar Therapeutics · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  6. US 7659361

    Maleamic acid polymer derivatives and their bioconjugates

    Nektar Therapeutics · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  7. US 7655747

    Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

    Nektar Therapeutics · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  8. US 7608253

    Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)

    Nektar Therapeutics · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  9. US 7598338

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  10. US 7589157

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  11. US 7582284

    Particulate materials

    Nektar Therapeutics · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  12. US 7579444

    Polymer-factor IX moiety conjugates

    Nektar Therapeutics AL, Corporation · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted
  13. US 7569214

    Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

    Nektar Therapeutics AL, Corporation · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted
  14. US 7547509

    Cyanovirin variant-polymer conjugates

    Nektar Therapeutics AL, Corporation · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  15. US 7544738

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  16. US 7528202

    Poly (ethylene glycol) derivatives with proximal reactive groups

    Nektar Therapeutics AL, Corporation · Granted May 5, 2009 · Expires Apr 30, 2029

    granted
  17. US 7511094

    Water-soluble polymer alkanals

    Nektar Therapeutics AL, Corporation · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  18. US 7511095

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics AL, Corporation · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  19. US 7481212

    Increased dosage metered dose inhaler

    Nektar Therapeutics · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  20. US 7482024

    Compositions comprising an active agent

    Nektar Therapeutics · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  21. US 7473433

    Pulmonary delivery of polyene antifungal agents

    Nektar Therapeutics · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted
  22. US 7449201

    Storage stable power compositions of interleukin-4 receptor

    Nektar Therapeutics · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  23. US 7432330

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics AL, Corporation · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  24. US 7432331

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics AL, Corporation · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted